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Abstract 
This study investigated age-related changes in collagen solubility and collagen-linked fluorescence, and their relationship with the 
Maillard reaction. As a result of the collagen purification of rat lung samples, we obtained two pools of collagen with different degrees of 
solubility. The relative distribution of collagen between these two fractions was time-dependent, and the proportion of the smaller and less 
soluble fraction increased with time (r = 0.73, P < 0.0001). In this fraction, the intensity of fluorescence atExc 335 nm/Em 385 nm, 
and the total amount of pentosidine increased with age (r = 0.66, P < 0.002, and r = 0.69, P < 0.01, respectively). The mean values for 
fluorescence and pentosidine per milligram of collagen were, respectively, six and ten times greater in the less soluble fraction. In this 
fraction the pentosidine per milligram of collagen increased with age (r = 0.59, P < 0.03). Our results demonstrated the presence of 
pentosidine in rat lung collagen. Moreover, its accumulation i the less soluble fraction suggested a relationship between Maillard 
reaction products, physico-chemical changes in collagen solubility, and the ageing process in rat lungs. 
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1. Introduction 
Under physiological conditions, collagen undergoes 
gradual extracellular modifications, leading to the forma- 
tion of intermolecular crosslinks [1]. Crosslinked collagen 
displays modified physicochemical characteristics such as 
decreased solubility, increased mechanical resistance and 
some spectral changes [2-5]. As collagen is a long-lived 
protein, these modifications accumulate during its life 
span, and old collagenous tructures, like those found in 
aged animals, exhibit these properties to a higher degree 
[6-10]. 
Collagen crosslinking is generally attributed to two 
basic mechanisms. One of them, which is due to the 
activity of the lysyl-oxidase nzyme, leads to the formation 
of dehydrolysinenorleucine and other natural derivative 
Abbreviations: ECM, extracellular matrix; BSA, bovine serum albu- 
min; AGE, advanced glycation endproduct; TLC, thin layer chromatog- 
raphy; HFBA, heptafluorobutyric acid; HPLC, high performance liquid 
chromatography; AFU, arbitrary fluorescence unit. 
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bonds. The other is related to the in vivo Maillard reaction, 
in which the free amino groups of proteins react nonenzy- 
matically with reducing sugars to form aminoketoses 
(Amadori products) [11]. These products undergo a series 
of nonenzymatic rearrangements forming advanced glyca- 
tion endproducts (AGE) [12]. 
Maillard reaction chemistry has been studied by food 
and agricultural scientists [13,14] who have identified com- 
plex structures formed through irreversible reactions. It is 
generally accepted that in vivo, some of these products are 
stable, and that they accumulate in tissues, particularly in 
proteins with a slow turnover such as collagen. Thus, when 
blood glucose rises as in diabetes mellitus, the Amadori 
products are increased and AGE formation and accumula- 
tion are also increased [15-19]. Some authors have also 
suggested that in the physiopathology of diabetic compli- 
cations the ageing process is in some way accelerated [10]. 
Despite the fact that only a few AGE structures have 
been identified from living tissues, and that some of the 
lysyl-oxidase products have been found to be increased in 
diabetes [20], most authors assume that the characteristics 
of aged and diabetic collagen must be a consequence of 
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the AGE products, because of their spectral properties, 
fluorescence, browning, etc. [2-5,21]. An accurate valua- 
tion of nonenzymatic crosslinks in ageing and diabetes is 
therefore a key question. 
The relative contribution of enzymatic and nonenzy- 
matic mechanisms to age-related collagen changes remains 
unclear. Most in vitro studies made with rat tail tendons 
show that collagen incubated with reducing sugars under- 
goes modifications imilar to those found in diabetics or 
aged specimens [2,21-23]. Some authors have found that 
lysyl-oxidase or aldose reductase inhibitors inhibited in 
vivo the decrease in collagen solubility [24], but not the 
fluorescence [25], suggesting that each mechanisms is 
independent, Others have found that, both in vivo and in 
vitro, the increase in mechanical strength and fluorescence 
occurs in parallel [3,4,21]. 
The loss of elasticity that was found in aged and 
diabetic lungs [26,27], suggests the participation of AGE 
crosslinks. We have studied the fluorescence, pentosidine 
concentration a d solubility properties of rat lung collagen 
fractions at different ages in order to evaluate the func- 
tional deterioration of the pulmonary collagenous matrix 
with time and its possible relationship with the fluorescent 
nonenzymatic bonds. 
2. Materials and methods 
2.1. Chemicals 
All the chemicals used were of analytical reagent grade 
unless otherwise specified. 
2.2. Animals and surgical procedures 
Sprague-Dawley rats, aged 1, 7, 13, 19 and 25 months 
-4 animals per time period - ,  were sacrificed by decapita- 
tion under ether anaesthesia and their lungs were immedi- 
ately removed by standard surgical methods. The lungs 
obtained were individually washed with PBS (0.2 M phos- 
phate buffer (pH 7.4) containing 9 g/1 NaC1). The excess 
buffer was removed by drying tissues between two pieces 
of filter paper. The hilum to the secondary bronchia were 
eliminated by dissection. The residual tissue was weighed, 
and after the addition of 3 ml of 150 mM NaC1, 50 mM 
Tris (pH 7.4), was rapidly frozen, and stored at -80°C 
until processing. 
2.3. Extraction and purification 
All the extraction procedures were carried out at 4°C 
unless stated otherwise. The tissues were homogenized in
150 mM NaCI, 50 mM Tris (pH 7.4) (5% w/v)  in a 
Kinematica Polytron (Buchs, Switzerland) for 1 min, at 
maximum r.p.m, in an ice bath. The crude homogenate 
was centrifuged at 15000 X g for 15 rain (Sorvall RC-24, 
DuPont, Newtown, CT, USA), and the resulting pellet was 
washed 3 times with 1 M KC1. The material was then 
stirred overnight in 1% Triton X-100 (Serva), and washed 
3 times with 1% Triton, 1 M KC1, and with 150 mM NaCI, 
all in 50 mM Tris (pH 7.4), respectively. The residual 
pellet, assumed to be extracellular matrix material (ECM), 
was washed 3 times with acetone, and then dried with 
diethyl ether at room temperature and subsequently 
weighed. 
The separation of collagen from elastin was carried out 
following the procedure described by Davis and Mackle 
[28]: the ECM was resuspended in phenol/acetic 
acid/water (1:1:1, w/v)  at 8 mg/ml, and incubated at 
45°C for 5 days. After this treatment, samples were cen- 
trifuged at 5000 X g for 30 min, at room temperature. The 
resulting pellet (which was taken to be elastin) was washed 
with water, dried, weighed and stored. The solubilized 
collagen was recovered from the phenol layer by extract- 
ing phenol using cold diethyl ether, until no phenol was 
spectrophotometrically detected in the organic phases. Af- 
ter centrifuging, the ether layers were removed, and the 
interface and aqueous layers were lyophilized. Lyophilized 
collagen was resuspended by gentle shaking in 4 ml of 
distilled water adjusted to pH 7.4 with solid Tris and 
centrifuged at 5000 X g for 10 min. The supernatant ob- 
tained was designated 'fraction A collagen'. The residual 
pellet, resuspended in 0.1 M CaCl2-Tris 20 mM (pH 7.4), 
was sonicated for 1 min, and then bacterial collagenase 
type IA (Sigma, St. Louis, MO, USA) was added to a final 
concentration of 280 U/ml  and incubated, while being 
constantly shaken for 24 h at 37°C. Samples were cen- 
trifuged at 15000 X g for 15 min. The resulting super- 
natant was stored and designated 'fraction B collagen'. 
Thus, after phenol/acetic acid treatment fraction A colla- 
gen is water-soluble, and fraction B collagen is water-in- 
soluble and collagenase-soluble. After collagenase diges- 
tion the 'final pellet', and all collagenous fractions were 
stored frozen at -80°C. 
2.4. Analytical methods 
Extraction procedures 
An aliquot of each washing step (except those per- 
formed with TX-100 and acetone) was kept and its protein 
content was determined by measuring its absorbance at 
280 nm, using BSA as a protein standard. To prove 
complete lipid elimination, a fraction (10%) of the total 
volume of supernatant from each sample of the TX-100 
and acetone washing steps was evaporated to dryness, 
resuspended in 2-propanol and submitted to TLC [29]. 
Hydroxyproline content 
Aliquots of fraction A collagen, fraction B collagen, 
elastin and the 'final pellet' from each sample were pro- 
cessed following the Stegeman method [30], in order to 
evaluate their hydroxyproline content. The elastin and 
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'final pellet' fractions were discarded once having ruled 
out the presence of collagen on the basis of their hydroxy- 
proline content. 
Measurements offluorescence 
Each collagen-containing sample was diluted to an equal 
hydroxyproline concentration (0.03 mg/ml).  For each 
sample, the intensity of fluorescence was measured against 
the appropriate blanks in a Shimadzu RF-500 spectro- 
fluorimeter at two distinct wavelengths: Exc 370 nm/Em 
440 nm; Exc 335 nm/Em 385 nm, under the same condi- 
tions. Throughout he report fluorescence values are ex- 
pressed in the same Arbitrary Fluorescence Unit (AFU). 
Quantification of pentosidine 
The pentosidine in the samples corresponding to frac- 
tion A collagen and fraction B collagen was quantified 
following the method of Odetti et al. [31]: amounts of 
collagen ranging between 0.12 to 2.11 mg were hydro- 
lyzed with deaerated 6 N HC1 in a nitrogen atmosphere at
I I0°C for 16 h. and then injected into a Waters HPLC 
system equipped with a C18 reverse phase column (Vydac 
218 TP). The mobile phase was a gradient of acetonitrile 
(from 10 to 17%) in water using HFBA 0.01 M as a 
counterion; the detection system was a 470 Waters fluores- 
cence detector set at 335 nm excitation and 385 nm 
emission with attenuation 4 and gain × 100. The pentosi- 
dine area was collected, dried and resuspended for a new 
separation. The collected sample was then separated using 
a cation-exchange column (SP-5PW, Waters, Milford, MA, 
USA) with a mobile phase characterized by a curvilinear 
gradient of NaC1 form 0 to 0.06 M in sodium acetate 0.02 
M (pH 4.7). The fluorometer was set as previously re- 
ported for the reverse phase column. 
2.5. Statistical studies 
Statistical studies were performed using SPSS-PC +® 
for Windows ®. A non-parametrical test (Kruskall-Wallis) 
was performed when necessary. Other data were analyzed 
by one-way-ANOVA, using Fisher's least significant dif- 
ference test. The 0.05 level was selected as the point of 
minimal statistical significance for each comparison. The 
Table 2 
Extracellular matrix material and its non collagenous fractions 
Age 1 7 13 19 25 
(months) 
ECM 31+3 126_+16 179_+19 144_+11 103_+11 
Elastin 20.14 21.84 18.08 21.09 18.97 
Final pellet 0.054 0.048 0.052 0.070 0.061 
After the initial washing steps the insoluble material was considered to be 
extracellular matrix material. 
It was submitted to a phenol/acetic acid/water (1:1:1, v/v)  treatment a
45°C for 5 days in order to separate the collagen from the elastin. 
The insoluble material obtained after total collagen solubilization was 
called 'final pellet'. 
ECM: mg ECM/g tissue; Elastin: % of elastin in ECM (w/w); Pellet: % 
Hydroxyproline in Final Pellet (w/w). 
Data are the mean values lbr the 4 animals at each age, except those 
referring to ECM expressed as mean + S.D. 
correlation between variables was evaluated using the 
Pearson correlation coefficient test. 
3. Results 
3.1. Extraction and purification 
Table 1 shows the salt-soluble protein extracted at each 
washing step and at each age. The total protein extracted 
was similar for all age groups with the notable exception 
of the 1 month old rats. After the third extraction step with 
both TX-100 and with acetone, TLC did not detect the 
presence of any lipids. 
Table 2 shows the weight of dried ECM per gram of 
tissue. It is noteworthy that the 1 month group differed 
significantly from the other time periods (P< 0.0001). 
The elastin fraction had a hydroxyproline content of 2% of 
its dry weight, which is similar to that described for other 
tissues and sources [32,33]. The total elastin obtained was 
constant hroughout he time periods considered, and it 
accounted for about 20% (w/w)  of the ECM material. 
Table 3 shows the hydroxyproline content of fractions 
A and B. The total hydroxyproline recovered in fractions 
A and B per gram of initial tissue for the 1 month old 
Table 1 
Protein elimination in washing steps 
Age (months) 1 7 13 19 25 
Homogenate 151 + 7 105 + 8 109 -+ 9 118 + 5 86 + 10 
KC I IM 110_+5 89_+8 104_+3 98+7 102+4 
KC1-Tris 23 _+ 2 17 + 2 20 _-+ 2 17 + 2 18 + 1 
NaCl-Tris 2 _+ 0.1 5 + 0.09 3 _+ 0.11 2 + 0.07 4 _ 0.1 
Total 286 + 20 216 + 19 237 + 19 236 _ 19 211 -+ 16 
Lung homogenates were subsequently washed in different buffered solutions. 
For each sample, the amount represents he protein extracted in 3 washing steps with the same extraction solution, except for the homogenization step. 
All values are expressed in mg of protein extracted per gram of initial tissue and correspond to the mean + S.D. value for the 4 animals at each age. 
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Table 3 
Recovery of hydroxyproline in fractions A and B 
Age (months) 1 7 13 19 25 
A a 0.40 +_ 0.04 * 1.54 ± 0.32 1.82 ± 0.43 1.19 + 0.13 1.23 + 0.34 
B ~ 0.06 ± 0.01 + 0.43 + 0.15 0.61 ± 0.08 0.44 + 0.09 0.45 ± 0.08 
A b 13.39 ± 4.54 12.22 ± 1.85 10.25 ± 2.47 13.28 + 1.72 12.24 + 3.96 
B b 2.10 ± 0.40 3.38 ± 0.74 3.48 -I- 0.78 4.90 _ 0.99 4.51 +__ 1.10 
%B c 14.08 21.76 25.74 26.79 27.46 
After elastin separation, collagen was submitted to a water extraction. 
The material obtained in this step was designated 'fraction A collagen'. 
The remaining material was solubilized by collagenase digestion. 
This was designated 'fraction B collagen'. 
a Milligrams of hydroxyproline/gram of tissue. 
b Milligrams hydroxyproline/gram of ECM. 
c % of the total sample hydroxyproline r covered as fraction B. 
* P<0.01; +P <0.0005. 
group was significantly different from that of  the other age 
groups (P  < 0.0001). The differences in the amount of  
hydroxyprol ine with respect to the weight of  the ECM 
between t ime periods were not significant. Fraction A had 
more than 75% of the total OH-Pro obtained (Fig. la). 
Studying the distribution of  bydroxyprol ine between the 
fractions A and B throughout the ages it could be seen that 
fraction A always accounted for more than 70% of the 
total hydroxyprol ine (Fig. 2a). The ratio between the 
amount of  hydroxyprol ine in fraction B and the total 
quantity of  hydroxyprol ine increased over t ime ( r  = 0.73, 
P < 0.0001) (Fig. 2a). These data showed a logarithmic 
relationship with age (y  = a + blnx, a = 14.00, b = 4.29, 
r 2= 0.991). After col lagenase digestion, the final pellet 
accounted for less than 1% (w/w)  of  the initial tissue 
weight. The hydroxyprol ine content of  this fraction showed 
no differences between age groups (Table 2), and repre- 
sented a mean of 0.040% of the total hydroxyprol ine. 
3.2. F luorescence results 
Fig. lb  and c show differences in f luorescence intensity 
between the fractions A and B. The average f luorescence 
intensity per mi l l igram of hydroxyprol ine in the fraction B 
was clearly higher than in the fraction A, at both wave- 
lengths (without taking the age of  the animals into ac- 
count). Taking into account the total hydroxyprol ine in 
each fraction, overall  f luorescence was found to be greater 
in ' fraction B'  (data not shown). 
Fig. 2b shows f luorescence values at Exc 370 nm/Em 
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Fig. 1. Mean values for the twenty samples are represented by the bars (without considering specimen age). ([]) Fraction A, (diagonal lines) fraction B. 
Vertical lines represent standard error. The differences between fractions A and B are significant for each variable compared at P < 0.001 significance 
level. For the measurements of fluorescence all the samples were diluted to equal hydroxyproline contents. Measurement was performed under the same 
conditions, and repeated three times for each sample. (a) % of total solubilized collagen present in each fraction; (b) fluorescence intensity/mg OH-Pro at 
Exc 370/Em 440 nm for each fraction; (c) fluorescence intensity/mg OH-Pro at Exc 335/Em 385 nm for each fraction, (d) pmol of pentosidine/mg 
collagen in each fraction; (e) % of total pentosidine recovered in each fraction. 
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Fig. 2. Each point represents the mean values of the four samples per 
time period. The vertical bar represents the standard eviation. For the 
measurements of fluorescence all the samples were diluted to equal 
hydroxyproline contents. Measurement was performed under the same 
conditions, and repeated three times for each sample. (0 )  Fraction A, 
(C)) fraction B; (a) % of total hydroxyproline content in fraction B with 
respect to the total hydroxyproline recovered; (b) fluorescence 
intensity/rag OH-Pro at Exc 370/Em 440 rim; (c) fluorescence inten- 
s i ty/mg OH-Pro at Exc 335/Em 385 nm, and (d) pmol of 
pentosidine/mg collagen. 
440 nm per milligram of collagen. The fluorescence inten- 
sity of fraction A increased slightly with age (r  = 0.47, 
P < 0.003), but differences between time periods were not 
significant. For fraction B no significant correlation with 
age was observed. While fluorescence intensity per mil- 
ligram of hydroxyproline at Exc 335 nm/Em 385 nm for 
fraction A showed no differences with age, fluorescence 
levels for fraction B increased with age ( r= 0.66, P < 
0.002) (Fig. 2c). 
3.3. Pentosidine measurements 
Without taking age into account, the content of pentosi- 
dine per mg of collagen in fraction B was almost 10 times 
higher than in fraction A (Fig. ld). Taking into account he 
total collagen recovered in each fraction, it can be shown 
that on average more than 75% of total pentosidine recov- 
ered was found in fraction B (Fig. le). 
Fig. 2d shows the results of pentosidine analysis by 
age-groups. The pentosidine per mg of collagen in both 
fractions increased with age (r  = 0.69, P < 0.03; r = 0.59, 
P < 0.03 for fractions A and B, respectively). The pentosi- 
dine levels, for the total collagen recovered in each frac- 
tion, increased with age (r  = 0.66, P < 0.005 for fraction 
A; r = 0.69, P < 0.01 for fraction B). 
The pentosidine content correlated significantly with the 
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Fig. 3. Relationship between fluorescence intensity at Exc 335 nm/Em 
385 nm, relative insolubility (expressed as % of collagen present in 
fraction B), and pentosidine content, in fraction B. (a) Pentosidine content 
(pmol pentosidine/mg collagen) vs. fluorescence intensity at Exc 335 
nm/Em 385 nm; (b) relative insolubility vs. pentosidine content (pmol of 
pentosidine/mg collagen); (c) relative insolubility vs. fluorescence inten- 
sity at Exc 335 nm/Em 385 nm. Points on the graph represent mean 
values for the four samples per time period. Bars represent the standard 
deviation of the measurements. Symbols used are: (C)) for I month 
group, (E3) for 7 months group, ('~-) for 13 months group, (•) for 19 
months group, and (~r) for 25 months group. 
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intensity of fluorescence at Exc 335 nm/Em 385 nm in 
fraction B collagen (r  = 0.54, P < 0.05) (Fig. 3a). Fig. 3b 
shows the relationship between the pentosidine content and 
the relative amount of collagen in fraction B, which corre- 
lated significantly ( r=0.73,  P <0.02). Moreover, the 
intensity of fluorescence at Exc 335 nm/Em 385 nm in 
fraction B also correlated with the percentage of total 
collagen in fraction B ( r= 0.50, P < 0.05) (Fig. 3c). It 
becomes apparent hat the insolubility correlates better 
with the pentosidine levels than with the fluorescence 
intensity, indicating the possible presence of other 
molecules fluorescing at this wavelength. 
4. Discussion 
Collagen and elastin are the most abundant proteins in 
the lung ECM. After washing to remove lipids and soluble 
proteins, a collagen purification procedure should include 
steps to separate these two proteins. The Davis and Mackle 
method was chosen for its efficiency in making this sepa- 
ration [28]. The conditions established by this procedure 
did not lead to modifications of fluorescence l vels at the 
wavelengths used [34]. Pentosidine stability in harsh acid 
conditions (6 M HC1, 110°C, 24 h) [35], and the mecha- 
nism of formation of this crosslink [36], permit o discard 
modifications on pentosidine l vels by this treatment. Most 
of the collagen obtained by this procedure became soluble 
in water (fraction A). The rest of the collagen remained 
insoluble under the same conditions (fraction B). A colla- 
genase digestion was used to solubilize the fraction B 
collagen. As can be inferred from the percentage of hy- 
droxyproline in the 'final pellet' and in the elastin fraction, 
no collagen remained in these residual materials. This two 
step method enabled complete lastin separation and colla- 
gen solubilization. Lung collagen is characterized by its 
extreme insolubility: established procedures, (e.g., pepsin- 
acetic acid digestion) can only extract 20-30% of total 
parenchymal collagen [37]. In our experiments direct reat- 
ment of samples with collagenase before elastin separation 
failed to achieve complete solubilization. Thus, the proce- 
dure described is a proper and suitable method for collagen 
purification, even in tissues with a relatively low collage- 
nous protein content (because of the presence of elastin), 
such as lungs. 
The total amount of collagen (fractions A + B) solubi- 
lized per gram of lung was similar for all the time-periods 
considered, except for the 1 month old rat group. In this 
time period the reduced recovery of collagen per gram of 
tissue may be due, both, to a higher solubility and to a 
greater hydration in young specimens [37,38]. In contrast, 
when total collagen recovery per gram of ECM material 
was considered, significant differences between time peri- 
ods were not observed. This could indicate a constant 
content of mature collagen in the extracellular matrix over 
time. 
Studying the relative distribution of total collagen be- 
tween fractions A and B, it could be observed that there 
was a significant increase in the water insoluble fraction 
with age. It is widely accepted that high degrees of cross- 
linking are associated with changes in the physical proper- 
ties of the collagen moieties, and influence collagen solu- 
bility. Thus, the observed changes in collagen distribution 
seem to point to a post-translational modification of the 
collagen. 
Fluorescence is commonly used to measure the rate of 
advanced Maillard reaction (i.e., nonenzymatic crosslinks). 
This measure was performed using two different wave- 
lengths. The first (Exc 370 nm/Em 440 nm) seems to be 
specific to the compound(s) derived by nonenzymatic gly- 
cation sensu strictu [39,40]. The second (Exc 335 nm/Em 
385 nm) is characteristic of glycoxidative product pentosi- 
dine (a previously described AGE crosslink). As shown in 
the results, fraction B was the more fluorescent fraction at 
both wavelengths. This suggests a greater abundance of 
Maillard reaction products in this fraction. 
Studying the evolution of fluorescence l vels with age 
in fraction B, values at Exc 370 nm/Em 440 nm showed 
no increase with age. In contrast fluorescence intensity at 
Exc 335 nm/Em 385 nm correlated with age. This sug- 
gests that pentosidine-like fluorescence is a better measure 
for AGE products in rat lungs than measurements at Exc 
370 nm/Em 440 nm, a finding which is in line with 
previous results [34]. 
The pentosidine measurements demonstrate hat the wa- 
ter insoluble fraction is highly rich (more than 75% of total 
pentosidine) in this known crosslink. This seems to indi- 
cate a relationship between the amount of pentosidine and 
the insolubility of collagen. This contrasts with recent 
reports where the pentosidine ffect in cross-linking is 
given relatively less importance [5,41], This discrepancy 
between results may be related to differences in the solubi- 
lization methods, the effects of solubilizing chemicals on 
unknown crosslinks, and the source and pretreatment of
the collagen used in these reports. The presence of pentosi- 
dine in fraction A and its increase with time, seems to 
contradict the observed relationship between the presence 
of pentosidine and the lower solubility of collagen. How- 
ever, the fact that the pentosidine per mg of collagen in 
fraction B is always higher than in fraction A suggests, in 
the context of the present study, the need for a minimum 
number of pentosidine crosslinks per molecule to insolubi- 
lize the collagen moieties. 
The levels of pentosidine per mg of collagen found in 
this study are in line with the results of other similar 
studies [42-44]. It is worth noting that the maximum levels 
we obtained (about 120 pmol/mg collagen, in the aged 
rats) were similar to those obtained for the higher values 
observed for other tissues in vivo (about 150 pmol/mg 
collagen in the human tracheal cartilage, 130 pmol/mg 
collagen in the human dura) [43]. The increase in pentosi- 
dine content with age is in line with that described for 
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other organs [42,43]. Thus, older rats showed similar val- 
ues (90-120 pmol/mg collagen) to those observed in 
other aged mammals (e.g., about 90 pmol/mg collagen in 
human skin from 90 year old individuals). This, and the 
different life-spans of the studied species trongly suggest 
a 'maximum possible level' for pentosidine concentration, 
which is reached in the last stages of life. This hypothesis 
seems to be feasible, despite the differences in turnover for 
each tissue and collagen type, which, in turn, could be one 
of the major factors influencing the pentosidine content. 
This would support he argument for using pentosidine as 
an age-marker in the context of the Maillard reaction 
theory of ageing. 
Although the correlation between pentosidine content 
and fluorescence at 335 nm excitation 385 nm emission 
was significant, we cannot rule out the presence of other 
molecules fluorescing at this wavelength. In fact, a recent 
report [45] has noted the existence of adducts of proteins 
and lipid peroxidation derived products, which fluoresce at 
this wavelength. However, the relative contribution, if any, 
of lipid peroxidation products to the crosslinking (and 
subsequent relative solubility) of collagen will not be 
completely elucidated until the identification and quantifi- 
cation of these products has been made possible. The 
stabilization in the values observed for older rats was in 
line with previous results. This could be related to several 
physiopathological mechanisms [34]. 
The relationship between lower solubility, fluorescence, 
and the presence of pentosidine, in rat lung collagen, 
strongly suggests the participation of Maillard reaction 
(glycoxidation and glycation products) in the physico- 
chemical properties that characterize the aged lung colla- 
gen. Thus, the qualitative changes in collagen with age 
could be due to an accumulation of fluorescent products 
(like pentosidine) with cross-linking properties. As several 
studies have stated [35,36], the in vivo origin of this 
molecule is still unclear, but we must remember that 
pentosidine formation requires oxidative conditions [41]. 
As the lungs possess one of the highest 02 tensions of the 
body, it is easy to establish a causal ink between the high 
levels of glycoxidation products (e.g., pentosidine) ob- 
served in this study and the oxidative conditions of the 
lung microenvironment. In fact, the lung is a known 
'target' for free radical reactions [46]. 
The in vivo Maillard reaction has been linked with 
several changes in the physico-chemical properties of the 
proteins affected, including protein-protein i teractions, 
ligand binding, urea-breaking time, etc. It has also been 
associated with structural molecular changes. It is gener- 
ally assumed that these changes must increase in proteins 
with a long life-span (like collagen). They could also 
account for some functional changes because of the inter- 
dependence between protein structure and function. It is 
known that there is a general oss of tissue elasticity with 
age. The increased glycation in lung collagen probably 
interferes with the functional properties of extracellular 
matrix components, not only changing their mechanical 
properties, but also altering the normal cell-matrix interac- 
tions in the lung. It is also known that the accumulation of
AGE in the matrix jeopardizes the vasodilator effects of 
nitric oxide [47], and in lungs, this probably contributes to 
an impairment of the pulmonary microcirculation. More- 
over, the AGE accumulation i aged lungs may contribute 
to the pathophysiology of senile emphysema, by causing 
structural disturbances in the extracellular matrix. Further- 
more, the increased oxidative stress present in smokers 
could favour glycoxidation product formation. This would 
contribute to the increased prevalence of pulmonary dis- 
function and pathology in these individuals. These hypo- 
thetical effects will be the focus of future investigations. 
In conclusion, this study presents evidence for the in 
vivo presence of AGEs in lungs, and for their relationship 
with changes in the physico-chemical properties of their 
extracellular matrix over time. It will hopefully contribute 
to existing knowledge and help towards a better under- 
standing of basic ageing mechanisms. 
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